In particular, D-2HG can inhibit BCAT1 and BCAT2, inducing glioma cells dependent on glutaminase and more sensitive to oxidative stress compared to IDH wild-type glioma cells [29]. The gene discussed is IDH1; the disease is central nervous system cancer.